About this item:

49 Views | 24 Downloads

Author Notes:

Address correspondence to: Mona Saraiya, MD, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta GA 30341. yzs2@cdc.gov

Author contributions were as follows: conceptualization (ME, HR, VS, MTM, MS), data curation (ME, HR, VS, MS), formal analysis (BH, ME, HR, MS), methodology (BH, ME, HR, VS, MTM, MS), supervision (MTM, MS), writing—original draft (BH, ME, HR, VS, MTM, MS), and writing—review and editing (BH, ME, HR, VS, MTM, MS).


Research Funding:

No financial disclosures were reported by the authors of this paper.


  • Science & Technology
  • Life Sciences & Biomedicine
  • Public, Environmental & Occupational Health
  • Medicine, General & Internal
  • General & Internal Medicine

Cervical Cancer Death Rates Among US- and Foreign-Born Women: US, 2005-2014


Journal Title:



Volume 56, Number 6


, Pages 869-874

Type of Work:

Article | Post-print: After Peer Review


Introduction: Historically, foreign-born women in the U.S. are less likely to be screened and are more likely to die from cervical cancer when compared with their U.S.-born counterparts. In order to inform prevention efforts and reduce this health disparity, mortality data were obtained from the National Center for Health Statistics to describe cervical cancer mortality among U.S.- and foreign-born women. Methods: Annual population estimates were obtained from the U.S. Census Bureau's American Community Survey from 2005 to 2014. From 2017 to 2018, age-adjusted mortality rates and rate ratios were calculated by nativity status, race/ethnicity, age, geographic region, and country of birth. Results: From 2005 to 2014, a total of 5,924 deaths from cervical cancer were recorded among the foreign-born population, compared with 33,893 deaths among U.S.-born women. Overall, foreign-born women had a lower cervical cancer mortality rate when compared with the U.S.-born women (rate ratio=0.95, 95% CI=0.92, 0.97). However, older foreign-born women had significantly higher mortality rates compared with U.S.-born women: aged 65–79 years (rate ratio=1.15, 95% CI=1.09, 1.22)and ≥80 years (rate ratio=1.43, 95% CI=1.32, 1.55). Women born in Mexico had significantly elevated rates of cervical cancer mortality (rate ratio=1.35, 95% CI=1.27, 1.42)when compared with U.S.-born women. Conclusions: Efforts that work to increase cervical cancer screening access and guideline compliance might further reduce the cervical cancer deaths in the U.S., and the excess burden observed among older foreign-born women.

Copyright information:

© 2019 American Journal of Preventive Medicine

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Export to EndNote